Fig. 1: Immunoparesis risk by non-clonal plasma cell fraction (NCPF).

Patients with NCPF-Enriched had significantly lower rates of moderate [one immunoglobulin (Ig)] or severe (2 or more Ig suppressed) immunoparesis.